Добірка наукової літератури з теми "Vaccination contre la grippe"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Vaccination contre la grippe".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Vaccination contre la grippe":
Bertholom, Chantal. "Vaccination contre la grippe." Option/Bio 28, no. 561-562 (May 2017): 14–15. http://dx.doi.org/10.1016/s0992-5945(17)30101-0.
Bertholom, Chantal. "Lupus et vaccination contre la grippe." Option/Bio 30, no. 595-596 (April 2019): 22–23. http://dx.doi.org/10.1016/s0992-5945(19)30084-4.
Gauthey, Laurent, Letizia Toscani, and Jean-Claude Schira. "Vaccination contre la grippe en Suisse." Sozial- und Pr�ventivmedizin SPM 42, no. 2 (March 1997): S107—S111. http://dx.doi.org/10.1007/bf01365164.
Guillermin, Alexandre, and Thierry Fumeaux. "Vaccination contre la grippe : du nouveau à l’horizon ?" Revue Médicale Suisse 13, no. 574 (2017): 1588. http://dx.doi.org/10.53738/revmed.2017.13.574.1588.
Nwosu, Andrea, Liza Lee, Kara Schmidt, Steven Buckrell, Claire Sevenhuysen, and Christina Bancej. "Rapport annuel national sur la grippe dans le contexte mondial, Canada, 2020–2021." Relevé des maladies transmissibles au Canada 47, no. 10 (October 14, 2021): 450–58. http://dx.doi.org/10.14745/ccdr.v47i10a02f.
Gonçalves, Elena, and Béhazine Combadière. "Prédire la réponse à la vaccination contre la grippe." médecine/sciences 36, no. 1 (January 2020): 31–37. http://dx.doi.org/10.1051/medsci/2019266.
Nau, Jean-Yves. "COVID-19 et vaccination contre la grippe: l’équation française." Revue Médicale Suisse 16, no. 699 (2020): 1330–31. http://dx.doi.org/10.53738/revmed.2020.16.699.1330.
Hanslik, T., and O. Launay. "Vaccination contre la grippe saisonnière : pour quelle efficacité chez l’adulte ?" La Revue de Médecine Interne 34, no. 12 (December 2013): 727–29. http://dx.doi.org/10.1016/j.revmed.2013.10.335.
Bresch, S., V. Queyrel, N. Tieulie, B. Rossignol, J. Castela, F. Sanderson, P. Jeandel, E. Rosenthal, P. Dellamonica, and J. G. Fuzibet. "Vaccination contre grippe H1N1 et maladies inflammatoires. Expérience d’un centre." La Revue de Médecine Interne 31 (June 2010): S122. http://dx.doi.org/10.1016/j.revmed.2010.03.175.
Sinilaite, Angela, Kelsey Young, and Robyn Harrison. "Sommaire de la Déclaration du Comité consultatif national de l’immunisation (CCNI) sur la vaccination antigrippale pour la saison 2021–2022." Relevé des maladies transmissibles au Canada 47, no. 09 (September 10, 2021): 410–19. http://dx.doi.org/10.14745/ccdr.v47i09a04f.
Дисертації з теми "Vaccination contre la grippe":
Baron, Geneviève. "La vaccination contre l'influenza chez les médecins omnipatriciens du Québec." Sherbrooke : Université de Sherbrooke, 2000.
Rouleau, Isabelle, and Isabelle Rouleau. "Épidémiologie des réactions d'allure allergique au vaccin contre la grippe pandémique A(H1N1)pdm09." Doctoral thesis, Université Laval, 2014. http://hdl.handle.net/20.500.11794/25434.
À l’automne 2010, le Québec a réalisé une campagne de vaccination de masse contre la grippe pandémique A(H1N1) en utilisant presque exclusivement un nouveau vaccin adjuvanté à l’AS03 (Arepanrix, GlaxoSmithKline). Les données de surveillance recueillies durant la campagne de vaccination ont montré que le taux de déclaration d’anaphylaxie, une réaction systémique sévère souvent attribuable à l’allergie, s’est avéré être supérieur à celui historiquement observé avec les vaccins contre la grippe saisonnière (8 contre < 1 cas par million de doses, respectivement). De plus, l’évaluation systématique des déclarations de manifestations cliniques inhabituelles (MCI) d’allure allergique a démontré que l’anaphylaxie avait été sous-diagnostiquée parmi les cas déclarés. Plus du deux tiers des MCI d’allure allergique observées durant la campagne de vaccination contre la grippe pandémique sont survenues chez des femmes. En tenant compte du nombre de doses administrées, les femmes avaient un risque deux fois plus élevé que les hommes. De plus, ce risque était plus important durant les années de vie reproductive, soit entre l’âge de 20 et 49 ans. Notre étude cas-témoin appariée a identifié certains facteurs de risque dont l’histoire personnelle et familiale d’allergie, la présence d’une infection respiratoire et la prise de médicaments pour l’asthme dans les jours précédant la vaccination, le statut de travailleur de la santé, et une vaccination dans les 4 premières semaines de campagne. Toutefois, aucun de ces facteurs n’expliquait une grande partie des anaphylaxies ou des MCI d’allure allergique. La présence d’une allergie aux œufs ou au poisson, deux composantes potentiellement allergènes du vaccin, ne s’est pas avéré être un facteur de risque significatif de MCI d’allure allergique. Nous avons aussi réalisé une étude clinique en allergie auprès d’une centaine de cas déclarés durant la campagne de vaccination contre la grippe pandémique qui a montré que peu de ces événements pouvaient être attribuables à une allergie IgE-dépendante au vaccin ou à ses composantes. Cette recherche a mis en évidence le risque plus élevé d’anaphylaxie et de MCI d’allure allergique chez les femmes en âge reproducteur mais n’a pas réussi à identifier d’autres facteurs de risque majeurs. Elle a toutefois démontré que le mécanisme habituellement évoqué pour les expliquer soit la présence d’IgE ciblant une des composantes du vaccin semble jouer un rôle très mineur.
Ann, Julie. "Développement et évaluation pré-clinique de nouveaux vaccins inactivés contre l’influenza et suivi de l’évolution des souches virales A/H3N2." Doctoral thesis, Université Laval, 2015. http://hdl.handle.net/20.500.11794/26792.
Influenza are respiratory pathogens responsible for seasonal epidemics and more occasionnally pandemics. During a season, 10 to 20 % of the global population is infected, which is a major public health problem. A/H3N2 viruses are associated with greater morbidity and mortality than A/H1N1 viruses. Vaccination remains the most effective way to control infections; however the effectiveness of these vaccines is short-lived and compromised in the event of a mismatch between circulating and vaccine strains. The first part of this thesis was devoted to the optimization of inactivated A/H3N2 vaccines by testing new adjuvants and routes of administration in mice and ferrets. It was shown that the adjuvant AS25 looks promising for the development of more effective vaccines. The second part of this thesis was devoted to the characterization of the molecular and antigenic evolution of A/H3N2 strains circulating in Quebec between 2009 and 2011. Our conclusion is that not only the number of mutations in the HA gene is important, but the nature and location of such mutations also play a key role in the antigenic drift. After characterizing the A/H3N2 strains under immune selection, we followed, in the third part of this thesis, an A/H3N2 strain under pressure with a new antiviral, laninamivir. Antivirals are the first line of defense in a pandemic or during an outbreak when there is a mismatch between circulating and vaccine strains. Our conclusion is that the viral fitness of our mutant strain is conserved in vitro but not in vivo. The different experiments done in this thesis have permitted to characterize the evolution of A/H3N2 strains and new ways of preventing or treating such infections.
Jordan, Fabrice. "Vaccination contre la grippe par voie intranasale : une étude de tolérance à l'Hôpital cantonal de Fribourg /." Genève : [s.n.], 2004. http://www.unige.ch/cyberdocuments/theses2004/JordanF/these.pdf.
Dioubate, Fatoumata. "Surveillance des effets secondaires du vaccin contre l'influenza : modifications du système, résultats observés et processus décisionnel lors de la campagne de vaccination massive contre l'influenza pandémique." Thesis, Université Laval, 2011. http://www.theses.ulaval.ca/2011/27774/27774.pdf.
Rondy, Marc. "Efficacité post autorisation de mise sur le marché de la vaccination antigrippale saisonnière contre l’hospitalisation avec une grippe confirmée virologiquement chez l’adulte en Europe." Thesis, Bordeaux, 2017. http://www.theses.fr/2017BORD0684/document.
Our objective was to measure seasonal influenza vaccine effectiveness (IVE) against hospitalisation with laboratory-confirmed influenza in Europe among adults. Between 2011 and 2017, we coordinated a multicenter case-control study in 29 hospitals in 12 countries. We pooled and analysed the data after every season. Between 2011-12 and 2016-17, we recruited 3436 influenza cases and 5969 controls. Pooled across seasons, IVE against any influenza was 26%; 40% patients aged 18-64 yeas, 25% among those aged 65-79 years, and 23% among those aged ≥80 years. Season specific IVE ranged between 15% in 2016-17 and 44% in 2013-14. IVE was particularly low among elderly in seasons dominated by the A(H3N2) viruses; it was 10% in 2011-12 and 2016-17 in people aged ≥80 years. Our results suggest a low to moderate IVE against influenza hospitalisation in adults. Evaluating complementary prevention options, such as prophylactic antiviral use, vaccination of health care workers and non-pharmaceutical interventions should be a priority
Guy, Bruno. "Étude des paramètres influençant l'efficacité de l'immunisation systémique pour l'induction de réponses muqueuses : application à la vaccination contre la grippe et l'infection à Helicobacter pylori." Lyon 1, 2000. http://www.theses.fr/2000LYO1T018.
Carnet, Flora. "Amélioration des protocoles vaccinaux contre la grippe équine et la rhinopneumonie : apport de l’iPPVO en tant qu’adjuvant dans le modèle équin, nouvelle approche de la mesure des anticorps neutralisants." Electronic Thesis or Diss., Normandie, 2023. http://www.theses.fr/2023NORMC413.
Equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1) are frequently described in many countries and are two endemic pathogens in the French equine population. These infectious diseases have important consequences both in terms of animal health and welfare and in terms of economic impact. The fight against these viruses is essentially based on the implementation of preventive measures such as vaccination. Despite this epizootics of EIV and EHV-1 are regularly declared in France and throughout the world. Neutralising antibodies, synthesised in response to infection or after immunisation, represent the main line of defence against these viruses. Improved vaccines and a wider range of tools to measure neutralising antibodies can be a valuable strategy in the fight against these viruses. In order to improve the efficacy of the vaccine response, both in magnitude and duration, the use of adjuvants is one way to improve immunogenicity. This thesis consisted, in the first instance, in establishing the proof of concept of the use of iPPVO as an innovative adjuvant in vivo in horses in the context of vaccination against EIV. For this purpose, antibodies were measured by SRH, a method for which the correlates of protection are well defined. The addition of iPPVO at vaccination significantly increased the antibody level to EIV and protection in horses up to 6 months after immunisation. In a second step, a new method for measuring EIV antibodies in serum based on impedancemetry was developed to improve on current methods and facilitate high throughput analysis. This neutralisation test correlated well with SRH test. Another study was performed, which demonstrated the adjuvant potential of iPPVO in horses during vaccination against EHV-1,4. The antibody response measured by serum neutralisation increased up to 5 months after immunisation. Finally, preliminary results on the mechanism of action of iPPVO on peripheral blood mononuclear cells demonstrated the importance of the interferon
Silva, Maria Laura. "The role of information in decision-making : an application to seasonal influenza vaccination policy." Thesis, Lyon, 2016. http://www.theses.fr/2016LYSE2019.
Seasonal influenza complications may cause hospitalization and even death. Despite the existence of vaccination recommendations to risk-groups, the vaccination coverage rates (VCR) in most European countries are low. Currently, few studies have been undertaken to explain this phenomenon. Information asymmetry between target groups, vaccinators and health authorities may possibly explain the low VCR. This thesis aimed at investigating (1) the economic burden of seasonal influenza in France, (2) the decision-making process for developing seasonal vaccination recommendations and (3) the incentives that would motivate general practitioners (GPs) to promote vaccination. A prospective survey conducted with laboratory-confirmed cases of influenza has shown the important economic impact of influenza under the perspective of the French Health Insurance. The main cost drivers are hospitalizations and daily allowances. Interviews with key actors, in France and in the Netherlands, involved in the development of vaccination recommendations explored their perceptions about the decision-making process and the influence of economic evaluations and other information on decisions. No systematic grading of the evidence was observed, whereas it was considered of low quality. Similar information was used in both countries, but as experts’ judgement was crucial for the process, differences about the target groups for vaccination were observed. Financial incentives to Dutch vaccinators were associated with their higher VCR. A pilot-study web-surveyed GPs, major vaccinators in France, about the influence of existing financial and non-monetary incentives. GPs were more likely to promote vaccination under non-monetary incentives. Probably because they were generally in favour of vaccinations, including the influenza vaccine; but they seek evidence proving the effectiveness of the vaccine and transparency of vaccination recommendations
Hossoé, Hayleno Santos. "DO EMISSOR AO RECEPTOR: os múltiplos caminhos da mensagem publicitária na campanha nacional de vacinação do idoso contra a gripe." Universidade Federal do Maranhão, 2007. http://tedebc.ufma.br:8080/jspui/handle/tede/868.
This research has as main objective to evaluate the reception and the adequacy of the advertising of the Campanha Nacional de Vacinação do Idoso Contra a Gripe of the district of São Luís do Maranhão in the year of 2006, considering its goals and its proposal of communication. Therefore, an ex-post evaluation of the implementation of the program of vaccination, classified as process of evaluation, was carried through aiming to relating the adequacy of the advertising campaign to the objectives and goals of this program, using an exploratory and qualitative approach. Documentary research, direct observation and focal group were used as techniques for data collection. Six participants of third age focal groups were carried through after the propagation of the 2006 campaign, in order to apprehend the generated effect of the communicative process in its target public. The accomplishment of each focal group was segmented in two stages. The first one was guided by a halfstructuralized script in order to motivate the quarrel of the participants on the campaign without showing its parts. The second stage was based on the exposition of the advertising parts of the campaign in order to stimulate the memory of the participants and to make possible the apprehension of the reception of the message without the interference of any imperfection in the distribution of the communication. The data collected through direct observation and the focal group participants` comments made possible the constitution of a research corpus on which an Analysis of Content was carried through by techniques of Thematic Analysis, with the purpose to compose an index which makes possible to extract, to classify and to regroup the speech of the subjects, in order to allow the identification of the elements that constituted the reception of the advertising campaign from the point of view of the integrants of its target public. Through the Thematic Analysis and the evaluation of the implementation process, it was possible to conclude that imperfections occurred in the process of distribution of parts of the advertising campaign, but they did not harm the positive results and reached number of vaccine covering in the year of 2006.
Esta pesquisa tem como principal objetivo avaliar a recepção e a adequação da publicidade da Campanha Nacional de Vacinação do Idoso Contra a Gripe do ano de 2006, no município de São Luís do Maranhão, frente a suas metas e a sua proposta de comunicação. Dessa forma, foi realizada uma avaliação ex post, classificada como avaliação de processo, no que se refere à implementação do programa, com o propósito de relacionar a adequação da campanha publicitária aos objetivos e metas do programa, utilizando uma abordagem exploratória e qualitativa. Como técnicas para coleta de dados foram utilizadas a pesquisa documental, a observação direta e o grupo focal. Foram realizados seis grupos focais com integrantes de grupos da terceira idade, após a veiculação da campanha de 2006, a fim de apreender os efeitos do processo comunicativo gerados em seu público-alvo. A realização de cada grupo focal foi segmentada em duas etapas, sendo a primeira orientada por um roteiro semiestruturado, de modo a motivar a discussão dos participantes sobre a campanha sem que fossem exibidas peças da mesma. A segunda etapa foi baseada na exposição das peças publicitárias da campanha como forma de estimular a lembrança dos participantes e possibilitar a apreensão da recepção da mensagem sem a interferência de possíveis falhas na distribuição da comunicação. Os dados coletados através da observação direta e do grupo focal possibilitaram a constituição de um corpus de pesquisa sobre o qual foi realizada uma Análise de Conteúdo, através das técnicas de Análise Temática, com a finalidade de compor um índex como forma de extrair, classificar e reagrupar as falas dos sujeitos, de modo a permitir a identificação dos elementos que constituíram a recepção da campanha publicitária do ponto de vista de integrantes de seu público-alvo. Através da Análise Temática e da avaliação do processo de implementação, foi possível concluir que ocorreram falhas no processo de distribuição das peças publicitárias da campanha, mas que não chegaram a prejudicar os bons resultados e índices de cobertura vacinal alcançados no ano de 2006.
Книги з теми "Vaccination contre la grippe":
Centre de prévention et de contrôle des maladies infectieuses (Canada), ed. Plan canadien de lutte contre la pandémie d'influenza. Ottawa, Ont: Santé Canada, Centre de prévention et de contrôle des maladies infectieuses, 2004.
Canada, Canada Health, and Canada Santé Canada, eds. Access to the seasonal flu vaccine in Canada: How the flu shot makes its way from the laboratory to the doctorgass office = Accès au vaccin contre la grippe saisonnière au Canada : comment le vaccin contre la grippe se rend du laboratoire jusqu'au cabinet médical. Ottawa, Ont: Health Canada = Santé Canada, 2007.
Houdret, Jean-Claude. La grippe ça se soigne: Comment reconnaître les différentes formes de grippe et chasser les virus, la prévention et la vaccination, savoir soigner rhume, rhino-pharyngite, sinusite, etc. Paris: M.A. éd., 1990.
International Conference on Options for the Control of Influenza (3rd 1996 Cairns, Australia). Options for the control of influenza III: Proceedings of the Third International Conference on Options for the Control of Influenza, Cairns, Australia, 4-9 May, 1996. Edited by Brown Lorena E, Hampson Alan W, and Webster Robert G. 1932-. Amsterdam: Elsevier, 1996.
Wals, Philippe De. Évaluation d'une campagne d'information télévisée sur l'influenza: Rapport de recherche. Sherbrooke, Qué: Centre de recherche en gérontologie et gériatrie, Institut universitaire de gériatrie de Sherbrooke, 1999.
Mauritania. Ministère de la santé et des affaires sociales. Plan stratégique national de prévention et de lutte contre la grippe aviaire 2006-2007. Nouakchott]: République Islamique de Mauritanie, Commission nationale permanente de surveillance de la grippe aviaire, 2006.
Saluzzo, Jean-François. La saga des vaccins: Contre les virus. Paris: Belin-pour la science, 2011.
P, Coursaget, Tong M. J, Institut national de la santé et de la recherche médicale (France), and Université de Tours, eds. Progress in hepatitis B immunization: Proceedings of a symposium = La vaccination contre l'hépatite B. Paris: Les editions INSERM ; London ; Paris : John Libbey Eurotext, 1990.
Ruata, Carlo. Contre la vaccination: Compte rendu du retentissant procès du Dr. Carlo Ruata et son acquittement. [Québec?: s.n.], 1996.
Seth, Catriona. Les rois aussi en mouraient: Les Lumières en lutte contre la petite vérole. Paris: Desjonquères, 2008.
Частини книг з теми "Vaccination contre la grippe":
Bodelet, Céline, and Aurélie Gauchet. "La vaccination contre la grippe chez les professionnels de santé travaillant en établissement." In Pratiques et interventions en psychologie de la santé, 49–62. Editions des archives contemporaines, 2020. http://dx.doi.org/10.17184/eac.3185.
Emery, Grégory. "Vaccination contre la grippe A (h1n1) : de la théorie à la pratique." In Traité de bioéthique, 458. ERES, 2010. http://dx.doi.org/10.3917/eres.hirsc.2010.01.0458.
Ajjan, Nizar. "Contre-indications des vaccinations." In La vaccination, 63–67. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70692-9.50008-8.
Denis, François. "30 Vaccination contre l’hépatite B." In Hépatite B, 485–502. EDP Sciences, 2020. http://dx.doi.org/10.1051/978-2-84254-223-8-033.
Denis, François. "30 Vaccination contre l’hépatite B." In Hépatite B, 485–502. EDP Sciences, 2020. http://dx.doi.org/10.1051/978-2-84254-223-8.c033.
Roure-Mariotti, M. C., and V. Federico-Roure. "Certificat de Contre-Indication à une Vaccination (Enfant/Adulte)." In 80 certificats et formulaires administratifs médicaux, 195–98. Elsevier, 2007. http://dx.doi.org/10.1016/b978-2-294-08902-2.50042-0.
"Histoire de la vaccination contre le virus de l’hépatite B." In De la jaunisse à l'hépatite C, 63–72. EDP Sciences, 2020. http://dx.doi.org/10.1051/978-2-84254-203-0.c009.
Bauquier, Charlotte, and Marie Préau. "La sexualité comme facteur de risque et la vaccination contre les papillomavirus humains." In Sexualité, savoirs et pouvoirs, 73–83. Les Presses de l’Université de Montréal, 2019. http://dx.doi.org/10.1515/9782760640900-006.
Bouchaud, O., P. H. Consigny, M. Cot, G. Le Loup, and S. Odermatt-Biays. "Liste des centres de vaccination habilités à effectuer la vaccination anti-amarile et à délivrer les certificats internationaux de vaccination contre la fièvre jaune, juillet 2018." In Médecine des Voyages et Tropicale, 341–56. Elsevier, 2019. http://dx.doi.org/10.1016/b978-2-294-76382-3.00015-2.
Roberts, Jennafer, and Lisa Mitchell. "« Ton corps, ta décision » : perspective anthropologique sur la réticence à la vaccination contre le VPH." In La santé publique à une ère marquée par le doute : origines religieuses et culturelles de l’hésitation des Canadiens face à la vaccination, 262–86. Éditions de l'Université de Sherbrooke, 2019. http://dx.doi.org/10.17118/11143/16021.
Тези доповідей конференцій з теми "Vaccination contre la grippe":
Stojanovski, Zoran, Goran Andonovski, Miralem Jukic, and Olgica Kuzarevska-Blazevska. "Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa3670.
Звіти організацій з теми "Vaccination contre la grippe":
Torre, Costanza. Considérations clés : Mobiliser les « personnes en déplacement » pour promouvoir l’acceptation du vaccin contre la COVID-19 en Italie. SSHAP, May 2022. http://dx.doi.org/10.19088/sshap.2022.023.
Ripoll, Santiago, Tabitha Hrynick, Ashley Ouvrier, Megan Schmidt-Sane, Federico Marco Federici, and Elizabeth Storer. 10 façons dont les gouvernements locaux en milieu urbain multiculturel peuvent appuyer l’égalité vaccinale en cas de pandémie. SSHAP, January 2023. http://dx.doi.org/10.19088/sshap.2023.001.
Hrynick, Tabitha, and Megan Schmidt-Sane. Note d’Orientation sur l’Engagement Communautaire Concernant la Riposte Contre la Flambée Epidémique de Choléra dans la Région Afrique de l’Est et Australe. Institute of Development Studies, May 2023. http://dx.doi.org/10.19088/sshap.2023.008.